GlassScriptPhysician profile
Austin Neil Ward
NPI 1780943274
$17,673.51
in general payments reported to CMS, 2019-2025
26 companies · $2,638 in 2025
The $2,638 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,108 · 2020: $3,494 · 2021: $443 · 2022: $660 · 2023: $2,111 · 2024: $2,221 · 2025: $2,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,216 · Travel and Lodging: $2,700 · Education: $53.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,216.17 |
| Travel and Lodging | $2,700.07 |
| Education | $53.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $6,012.94 | 2019-2025 | Mitris Resilia Mitral Valve, Pascal, Inspiris Resilia Aortic Valve |
| Intuitive Surgical, INC. | $2,758.51 | 2020-2025 | |
| W. L. Gore & Associates, INC. | $2,041.24 | 2019-2020 | |
| Abbott Laboratories | $1,698.14 | 2019-2024 | Mitraclip, Cardiomems |
| Atricure, INC. | $1,669.15 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
| Medtronic Vascular, INC. | $1,321.54 | 2019 | |
| Abiomed | $726.45 | 2019-2025 | Impella |
| Medtronic, INC. | $202.07 | 2024-2025 | Valiant Captivia, Endurant Iis |
| Irhythm Technologies, INC. | $200.07 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $171.56 | 2022-2025 | Repatha, Repatha |
| Ethicon US, LLC | $123.03 | 2021-2023 | Surgicel Nu-Knit |
| Zimmer Biomet Holdings, INC. | $108.45 | 2020 | |
| Janssen Pharmaceuticals, INC | $101.60 | 2022-2024 | Xarelto |
| Ethicon INC. | $92.26 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.71 | 2023-2024 | Lifevest |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $73.41 | 2023-2024 | Verquvo, Lagevrio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.20 | 2022-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $42.67 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $37.27 | 2024 | |
| Boston Scientific Corporation | $33.42 | 2023 | Ekosonic, Watchman Access System |
| Philips North America LLC | $30.70 | 2022-2024 | (Ck4) Mcot |
| Lantheus Medical Imaging, INC. | $20.12 | 2023 | Definity |
| Kiniksa Pharmaceuticals International, Plc | $19.92 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $18.36 | 2024 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $16.87 | 2022 | |
| Becton, Dickinson and Company | $15.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.